Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Methods (San Diego, Calif.)|August 18, 2012
Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferaseGrégory Neveu, Patricia Cassonnet, Pierre-Olivier Vidalain, et al.
Antiviral Research|May 15, 2026
A subset of Histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infectionMarlène Roy, Emilie Bardel, Laura Gromolard, et al.
Journal of Virology|January 20, 2012
Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral componentMehdi Bouraï, Marianne Lucas-Hourani, Hans Henrik Gad, et al.
Nature Communications|May 28, 2024
The low-density lipoprotein receptor and apolipoprotein E associated with CCHFV particles mediate CCHFV entry into cellsMaureen Ritter, Lola Canus, Anupriya Gautam, et al.
Viruses|September 28, 2021
A Bioluminescent 3CL<sup>Pro</sup> Activity Assay to Monitor SARS-CoV-2 Replication and Identify InhibitorsCyrille Mathieu, Franck Touret, Clémence Jacquemin, et al.
Plos Pathogens|December 17, 2011
IRGM is a common target of RNA viruses that subvert the autophagy networkIsabel Pombo Grégoire, Clémence Richetta, Laurène Meyniel-Schicklin, et al.
Emerging Microbes & Infections|September 17, 2025
<i>In Vitro</i> and <i>Ex Vivo</i> evidence that pharmacological induction of the hypoxia response pathway efficiently restricts measles and Nipah virus infectionsLola Canus, Clémence Jacquemin, Walid El Orch, et al.
EMBO Molecular Medicine|February 16, 2026
Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signalingAdeline Cezard, Déborah Brea-Diakite, Virginie Vasseur, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2024
Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discoveryLaurène Meyniel-Schicklin, Jérôme Amaudrut, Pierre Mallinjoud, et al.
Pageof 9